Equate Nicotine Lozenge
Product Images NDC 49035-190

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Equate Nicotine (NDC 49035-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wal-mart Stores Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

190 2e Nicotine Lozenge Image

190 2e Nicotine Lozenge Image
Equate Nicotine Lozenges, 4 mg nicotine polacrilex, oral lozenge for smoking cessation aid. Cherry flavor, package contains 108 lozenges. Label shows bottle with blue cap, includes usage warnings, directions, Drug Facts panel, and Wal-Mart Stores Inc as labeler. NDC 49035-190.*
FDA Label Image

Wallet Card (Export 00)

Wallet Card (Export 00)
A wallet card titled 'WALLET CARD' featuring a prompt that reads 'My most important reasons to quit smoking are:' followed by six blank lines for personal reasons to be filled in. The card has a simple bordered design and is intended as a motivational aid for smokers trying to quit.*
FDA Label Image

Wallet Card (Image 01)

Wallet Card (Image 01)
An instructional wallet card listing phone numbers for help quitting smoking, including contacts for the American Lung Association, American Cancer Society, and American Heart Association, along with a space labeled 'Quitting Buddy or Friend who has Quit.'*
FDA Label Image

Smoke Free Logo (Image 02)

FDA Label Image

Upc Example (Image 03)

FDA Label Image

Reminder Stickers (Image 04)

Reminder Stickers (Image 04)
An instructional diagram showing a schedule for taking Equate Nicotine Polacrilex 4 mg lozenges. It is divided into four colored sections labeled Step 1 through Step 3 and Ex-Smoker, indicating the recommended lozenge frequency from week 1 to week 10 and 12 weeks after the quit date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.